Learning from history to improve the performance of blood purification devices and dialysis membranes: from engineering points of view.

IF 1.1 4区 医学 Q4 ENGINEERING, BIOMEDICAL Journal of Artificial Organs Pub Date : 2025-01-16 DOI:10.1007/s10047-024-01489-1
Kiyotaka Sakai, Takehiro Miyasaka
{"title":"Learning from history to improve the performance of blood purification devices and dialysis membranes: from engineering points of view.","authors":"Kiyotaka Sakai, Takehiro Miyasaka","doi":"10.1007/s10047-024-01489-1","DOIUrl":null,"url":null,"abstract":"<p><p>Abel JJ, Rowntree LG and Turner BB (Baltimore Trio) proposed the concept of vividiffusion and developed a vividiffusion apparatus in 1912. In a 1914 paper, they laid out the most important rule of device design. We named this rule an ART law taken from the initials of the Baltimore Trio. The ART law means that a blood purification device with a shape that can secure as large a dialysis membrane area as possible for as small a volume of blood filling as possible will achieve high dialysis performance. Rather than using 8 mm inner diameter collodion tubes in the original vividiffusion apparatus, the solution to the device shape that fits this rule is to hold down the tube from both top and bottom to make it as flat as possible, or if it is a flat membrane, to bring two flat membranes as close together as possible, and in the case of tubes and hollow fibers, to make their inner diameter as small as possible of approximately 200 μm. In other words, the dialysis performance is greatly improved by narrowing the blood flow path. This is exactly the ART law, predicting the shape of today's blood purification devices.</p>","PeriodicalId":15177,"journal":{"name":"Journal of Artificial Organs","volume":" ","pages":""},"PeriodicalIF":1.1000,"publicationDate":"2025-01-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Artificial Organs","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.1007/s10047-024-01489-1","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"ENGINEERING, BIOMEDICAL","Score":null,"Total":0}
引用次数: 0

Abstract

Abel JJ, Rowntree LG and Turner BB (Baltimore Trio) proposed the concept of vividiffusion and developed a vividiffusion apparatus in 1912. In a 1914 paper, they laid out the most important rule of device design. We named this rule an ART law taken from the initials of the Baltimore Trio. The ART law means that a blood purification device with a shape that can secure as large a dialysis membrane area as possible for as small a volume of blood filling as possible will achieve high dialysis performance. Rather than using 8 mm inner diameter collodion tubes in the original vividiffusion apparatus, the solution to the device shape that fits this rule is to hold down the tube from both top and bottom to make it as flat as possible, or if it is a flat membrane, to bring two flat membranes as close together as possible, and in the case of tubes and hollow fibers, to make their inner diameter as small as possible of approximately 200 μm. In other words, the dialysis performance is greatly improved by narrowing the blood flow path. This is exactly the ART law, predicting the shape of today's blood purification devices.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
从历史中吸取教训,提高血液净化装置和透析膜的性能:从工程的角度来看。
Abel JJ, Rowntree LG和Turner BB (Baltimore Trio)于1912年提出了活体扩散的概念,并开发了活体扩散装置。在1914年的一篇论文中,他们列出了设备设计中最重要的规则。我们将这条规则命名为ART法律,取自巴尔的摩三人组的首字母缩写。ART法意味着,在尽可能小的血液填充量下,能够确保尽可能大的透析膜面积的形状的血液净化装置将实现高透析性能。而不是使用8毫米内径胶管原vividiffusion装置,解决设备形状符合这个规则是按住管从顶部和底部,让它尽可能平坦的,或者如果它是一个平坦的膜,把两个平膜尽可能接近,在中空纤维膜管和的情况下,使他们的内径尽可能小的大约200μm。换句话说,通过缩小血液流动路径,透析性能大大提高。这正是ART定律,预测了今天血液净化装置的形状。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Journal of Artificial Organs
Journal of Artificial Organs 医学-工程:生物医学
CiteScore
2.80
自引率
15.40%
发文量
68
审稿时长
6-12 weeks
期刊介绍: The aim of the Journal of Artificial Organs is to introduce to colleagues worldwide a broad spectrum of important new achievements in the field of artificial organs, ranging from fundamental research to clinical applications. The scope of the Journal of Artificial Organs encompasses but is not restricted to blood purification, cardiovascular intervention, biomaterials, and artificial metabolic organs. Additionally, the journal will cover technical and industrial innovations. Membership in the Japanese Society for Artificial Organs is not a prerequisite for submission.
期刊最新文献
Learning from history to improve the performance of blood purification devices and dialysis membranes: from engineering points of view. Barriers and solutions for introducing donation after circulatory death (DCD) in Japan. Incidence of neutrophil extracellular traps (NETs) in different membrane oxygenators: pilot in vitro experiments in commercially available coated membranes. Progress of extracorporeal centrifugal pumps for mechanical circulatory supports. Disseminated intravascular coagulation is associated with a poor outcome in patients with out-of-hospital cardiac arrest receiving VA-ECMO.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1